IDYAIDEAYA Biosciences, Inc.

39.67USD+2.06%Mkt Cap: 3.83B $P/E:

IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral,…

Key Statistics

Company
Market Cap3.83B $
Enterprise Value2.97B $
Revenue (TTM)234.13M $
Gross Profit-85.24M $
Net Income (TTM)-113.70M $
Revenue/Share2.617 USD
Last Price39.67 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees145
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45166A1025
Valuation
P/E (Trailing)
P/E (Forward)-9.52
PEG
EV/EBITDA-13.88
EV/Revenue12.70
P/S16.12
P/B3.14
EPS (TTM)-1.93
EPS (Forward)-4.11
52W Range
23.2395% of range40.58
52W High40.58 USD
52W Low23.23 USD
Profitability
Gross Margin-36.41%
Oper. Margin-1380.73%
EBITDA Margin-91.49%
Profit Margin-51.99%
ROE-11.11%
ROA-10.25%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-71.10M $
CapEx (TTM)2.37M $
FCF Margin-30.26%
FCF Yield-1.85%
Net Debt-799.65M $
Net Debt/EBITDA3.73
Balance Sheet
Debt/Equity0.03
Current Ratio10.45
Quick Ratio10.21
Book Value/Sh12.44 USD
Cash/Share8.591 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)52.15 USD
Upside (mean)+31.5%
Target Range31.00 USD65.00 USD
$31.00+31.5% to mean$65.00
# Analysts13
Ownership
Shares Out.96.49M
Float90.63M
Insiders2.19%
Institutions108.18%
Short Interest
Short Ratio10.4d
Short % Float12.21%
Short % Out.10.50%
Shares Short10.11M
Short (prev mo.)10.33M
Technical
SMA 5035.67 (+11.2%)
SMA 20033.22 (+19.4%)
Beta-0.09
S&P 52W Chg18.16%
Avg Vol (30d)706.97K
Avg Vol (10d)684.14K
Technical Indicators
RSI (14)68.2
MACD0.7447
MACD Signal0.5374
MACD Hist.+0.2073
BB Upper38.69 USD
BB Middle36.57 USD
BB Lower34.46 USD
BB Width11.56%
ATR (14)1.408 USD
Vol Ratio (20d)1.23x